Brief: Seres Therapeutics Announces Receipt Of $125 Mln Milestone From Nestlé Health Science
30/05/2023 21:02
May 30 (Reuters) - Seres Therapeutics Inc MCRB.O :
* SERES THERAPEUTICS ANNOUNCES RECEIPT OF $125 MILLION
MILESTONE
FROM NESTLÉ HEALTH SCIENCE FOLLOWING FDA APPROVAL OF VOWST™
* SERES THERAPEUTICS INC - IN ADDITION, SERES IS ELIGIBLE TO
RECEIVE PAYMENTS OF UP TO $225 MILLION FOR ACHIEVEMENT OF
SPECIFIED NET SALES MILESTONES
Source text for Eikon: ID:nBwc8RpBwa
Further company coverage: MCRB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47